Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

The incidence of depression and anxiety has surged among adults in the United States over the course of the COVID-19 pandemic, according to the Centers for Disease Control and Prevention (CDC). The CDC survey suggested that from 2019 to 2020, symptoms of anxiety disorders and depression have tripled and quadrupled, respectively. As you might expect, prescriptions for antidepressant and antianxiety drugs also have spiked, according to the telehealth platform iPrescribe. While many patients with severe or chronic depression or anxiety may need to continue using these medications long term, you may think that, given the return of opportunities for working…

Read More